Often used in conjunction with imaging, alpha-fetoprotein (AFP) remains the most widely used biomarker for hepatocellular carcinoma (HCC), but its diagnostic, prognostic, and surveillance capabilities are limited. Here, AFP is linked to hepatocellular carcinoma.